The Greater Philadephia Business Coalition on Health (GPBCH) issued a member action brief on "Covering Prescription Weight Loss Therapies to Address Obesity," which reviews the available evidence on effectiveness and safety (including side effects) of the new generation of obesity drugs and recommends that employers consider covering these drugs in concert with lifestyle change programs.
On March 7, the Greater Philadephia Business Coalition on Health (GPBCH) issued a member action brief on "Covering Prescription Weight Loss Therapies to Address Obesity." The brief reviews the available evidence on effectiveness and safety (including side effects) of the new generation of obesity drugs and recommends that employers consider covering these drugs in concert with lifestyle change programs.
Content for the Action Brief was gathered by Ileka Ifejika, a third year student in the Jefferson College of Pharmacy, doing an internship with GPBCH; a draft was reviewed by the GPBCH Employee Health and Well-being Interest Group, and 2 weight management clinicians.
Contributor: For Complex Cases, Continuity in Acute Care Is Necessary
April 23rd 2025For patients with complex needs and social challenges like unstable housing, the hospital has become their de facto medical home—yet each visit is a fragmented restart, without continuity, context, or a clear path forward.
Read More
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen